Theialife Appoints Thomas Ruggia as President and CEO to Help Advance Oral Myopia Therapy

Published on April 27, 2026
DOVER, Del.—Theialife, a late-stage clinical company advancing therapeutic solutions for ocular diseases, has announced the appointment of Thomas Ruggia as the company’s first president and CEO. Ruggia, based in New Jersey, will lead development, operational and corporate strategy as the company prepares for the planned initiation of Phase 3 development for its lead candidate, ND10, an oral therapy being developed to slow pediatric myopia progression. Sundeep Aurora, the company’s co-founder, will continue to oversee scientific research and development and will serve as chairman.
Continue reading on website
Other news

Alternative Eyewear and East Optical Partner to Bring MyoPro Myopia Lenses to Canada

April 27, 2026
TORONTO—Alternative Eyewear and East Optical have announced an exclusive agreement to distribute East Optical’s MyoPro myopia control lenses in Canada. Through this agreement, Alternative Eyewear will serve as the exclusive provider of MyoPro lenses in the Canadian market, the companies said, ensuring that independent practices across Canada have access to advanced lens technology designed to supp

Prevent Blindness to Kick Off Its Focus on Eye Health Webinar Series Around the Theme of ‘Powering Partnerships to Advance Eye Health’

April 27, 2026
CHICAGO—Prevent Blindness, a nonprofit eye health organization, has announced it is kicking off the first webinar in its Focus on Eye Health Webinar Series on May 19, 2026. This year’s theme, “Powering Partnerships to Advance Eye Health,” will weave through all four webinars in the series during the year and will include expert- and patient-led presentations, on-demand educational content, resourc